ES2049617B1 - Procedimiento de preparacion de una composicion farmaceutica. - Google Patents
Procedimiento de preparacion de una composicion farmaceutica.Info
- Publication number
- ES2049617B1 ES2049617B1 ES09102518A ES9102518A ES2049617B1 ES 2049617 B1 ES2049617 B1 ES 2049617B1 ES 09102518 A ES09102518 A ES 09102518A ES 9102518 A ES9102518 A ES 9102518A ES 2049617 B1 ES2049617 B1 ES 2049617B1
- Authority
- ES
- Spain
- Prior art keywords
- poly
- procedure
- pharmaceutical composition
- butylucinucinate
- preparing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 2
- 102000055006 Calcitonin Human genes 0.000 abstract 1
- 108060001064 Calcitonin Proteins 0.000 abstract 1
- 101000904177 Clupea pallasii Gonadoliberin-1 Proteins 0.000 abstract 1
- 239000000579 Gonadotropin-Releasing Hormone Substances 0.000 abstract 1
- 102000005157 Somatostatin Human genes 0.000 abstract 1
- 108010056088 Somatostatin Proteins 0.000 abstract 1
- 101000857870 Squalus acanthias Gonadoliberin Proteins 0.000 abstract 1
- 229920002253 Tannate Polymers 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 229920002988 biodegradable polymer Polymers 0.000 abstract 1
- 239000004621 biodegradable polymer Substances 0.000 abstract 1
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 abstract 1
- 229960004015 calcitonin Drugs 0.000 abstract 1
- 238000007580 dry-mixing Methods 0.000 abstract 1
- 238000001125 extrusion Methods 0.000 abstract 1
- XLXSAKCOAKORKW-AQJXLSMYSA-N gonadorelin Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 XLXSAKCOAKORKW-AQJXLSMYSA-N 0.000 abstract 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 abstract 1
- 238000002513 implantation Methods 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 239000011859 microparticle Substances 0.000 abstract 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 abstract 1
- 229960000553 somatostatin Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
PROCEDIMIENTO DE PREPARACION DE UNA COMPOSICION FARMACEUTICA EN FORMA DE MICROPARTICULAS O DE UNA IMPLANTACION QUE COMPRENDE UN POLIMERO BIODEGRADABLE ESCOGIDO DE ENTRE POLI-1,4-BUTILENSUCCINATO, POLI-2,3-BUTILENSUCCINATO, POLI-1,4-BUTILENFUMARATO Y POLI-2,3-BUTILENFUMARATO, INCORPORANDO COMO SUBSTANCIA ACTIVA EL PAMOATO, TANNATO, ESTEARATO O PALMITATO DE UN PEPTIDO NATURAL O SINTETICO QUE COMPRENDE DE 3 A 45 AMINOACIDOS, TALES COMO LH-RH, SOMATOSTATINA, GH-RH O CALCITONINA, O UNO DE SUS ANALOGOS U HOMOLOGOS SINTETICOS. LA PREPARACION COMPRENDE MEZCLAR EN SECO LOS INGREDIENTES EN FORMA DE POLVO, PRECOMPRIMIR Y PRECALENTAR LA MEZCLA Y LUEGO EXTRUIR LA MEZCLA PRECOMPRIMIDA Y PRECALENTADA. EL PRODUCTO RESULTANTE DE LA ETAPA DE EXTRUSION PUEDE TRITURARSE A CONTINUACION Y FINALMENTE CRIBARSE.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH3616/90A CH681425A5 (es) | 1990-11-14 | 1990-11-14 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES2049617A1 ES2049617A1 (es) | 1994-04-16 |
| ES2049617B1 true ES2049617B1 (es) | 1997-03-16 |
Family
ID=4259807
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES09102518A Expired - Lifetime ES2049617B1 (es) | 1990-11-14 | 1991-11-13 | Procedimiento de preparacion de una composicion farmaceutica. |
Country Status (12)
| Country | Link |
|---|---|
| JP (1) | JPH04288021A (es) |
| AT (1) | AT397198B (es) |
| BE (1) | BE1004923A5 (es) |
| CA (1) | CA2055115A1 (es) |
| CH (1) | CH681425A5 (es) |
| DE (1) | DE4136930A1 (es) |
| ES (1) | ES2049617B1 (es) |
| FR (1) | FR2668707B1 (es) |
| GB (1) | GB2249725B (es) |
| IT (1) | IT1252870B (es) |
| NL (1) | NL9101877A (es) |
| SE (1) | SE506448C2 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH683149A5 (fr) * | 1991-07-22 | 1994-01-31 | Debio Rech Pharma Sa | Procédé pour la préparation de microsphères en matériau polymère biodégradable. |
| US5456917A (en) * | 1993-04-12 | 1995-10-10 | Cambridge Scientific, Inc. | Method for making a bioerodible material for the sustained release of a medicament and the material made from the method |
| US5945128A (en) * | 1996-09-04 | 1999-08-31 | Romano Deghenghi | Process to manufacture implants containing bioactive peptides |
| WO2004096178A1 (en) * | 2003-05-02 | 2004-11-11 | The University Of Nottingham | Nano and microparticle drug delivery systems comprising polyesters containing aliphatic dicarboxylate residues and residues of aliphatic polyols |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3978203A (en) * | 1974-07-12 | 1976-08-31 | Dynatech Corporation | Sustained release of pharmaceuticals from polyester matrices |
| US4481353A (en) * | 1983-10-07 | 1984-11-06 | The Children's Medical Center Corporation | Bioresorbable polyesters and polyester composites |
| US4962091A (en) * | 1986-05-23 | 1990-10-09 | Syntex (U.S.A.) Inc. | Controlled release of macromolecular polypeptides |
| GB2209937B (en) * | 1987-09-21 | 1991-07-03 | Depiopharm S A | Water insoluble polypeptides |
| CH672887A5 (es) * | 1987-10-14 | 1990-01-15 | Debiopharm Sa | |
| CH679207A5 (es) * | 1989-07-28 | 1992-01-15 | Debiopharm Sa | |
| IT1243390B (it) * | 1990-11-22 | 1994-06-10 | Vectorpharma Int | Composizioni farmaceutiche in forma di particelle atte al rilascio controllato di sostanze farmacologicamente attive e procedimento per la loro preparazione. |
-
1990
- 1990-11-14 CH CH3616/90A patent/CH681425A5/fr not_active IP Right Cessation
-
1991
- 1991-10-31 BE BE9101009A patent/BE1004923A5/fr not_active IP Right Cessation
- 1991-11-01 GB GB9123241A patent/GB2249725B/en not_active Expired - Fee Related
- 1991-11-04 FR FR9113563A patent/FR2668707B1/fr not_active Expired - Fee Related
- 1991-11-07 CA CA002055115A patent/CA2055115A1/en not_active Abandoned
- 1991-11-08 IT ITBS910119A patent/IT1252870B/it active IP Right Grant
- 1991-11-11 DE DE4136930A patent/DE4136930A1/de not_active Ceased
- 1991-11-11 NL NL9101877A patent/NL9101877A/nl active Search and Examination
- 1991-11-12 AT AT0223591A patent/AT397198B/de not_active IP Right Cessation
- 1991-11-13 SE SE9103348A patent/SE506448C2/sv not_active IP Right Cessation
- 1991-11-13 ES ES09102518A patent/ES2049617B1/es not_active Expired - Lifetime
- 1991-11-13 JP JP91297358A patent/JPH04288021A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| NL9101877A (nl) | 1992-06-01 |
| CA2055115A1 (en) | 1992-05-15 |
| CH681425A5 (es) | 1993-03-31 |
| ITBS910119A1 (it) | 1993-05-08 |
| ATA223591A (de) | 1993-07-15 |
| FR2668707B1 (fr) | 1995-05-24 |
| GB2249725B (en) | 1994-08-10 |
| SE9103348D0 (sv) | 1991-11-13 |
| GB2249725A (en) | 1992-05-20 |
| SE9103348L (sv) | 1992-05-15 |
| ES2049617A1 (es) | 1994-04-16 |
| DE4136930A1 (de) | 1992-08-20 |
| BE1004923A5 (fr) | 1993-02-23 |
| GB9123241D0 (en) | 1991-12-18 |
| SE506448C2 (sv) | 1997-12-15 |
| AT397198B (de) | 1994-02-25 |
| JPH04288021A (ja) | 1992-10-13 |
| IT1252870B (it) | 1995-06-28 |
| FR2668707A1 (fr) | 1992-05-07 |
| ITBS910119A0 (it) | 1991-11-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE1003093A3 (fr) | Procede de preparation d'une composition pharmaceutique sous forme de microparticules. | |
| HK65393A (en) | Slow-release pharmaceutical composition | |
| DE69115711D1 (de) | Verfahren zur arzneiformulierung sowie arzneimittel | |
| KR890001526A (ko) | 경구용 서방성 아세트 아미노펜 제형 및 이의 제조방법 | |
| KR850007559A (ko) | 조절 펩타이드의 삽입식 제형 | |
| NO173317C (no) | Fremgangsm}te for fremstilling av et fast farmas!ytisk preparat med forsinket frigj!ring | |
| DE3172223D1 (en) | Edible, pharmaceutical compositions and processes for making thereof | |
| DE69809074D1 (de) | Herstellung von arzneimitteln | |
| NO175240C (no) | Fremgangsmåte for fremstilling av et langsomt frigivende farmasöytisk preparat som omfatter sekundære granuler | |
| EA200100024A1 (ru) | Состав таблетки с делавирдином | |
| SE8303531D0 (sv) | Farmaceutisk komposition | |
| MY118835A (en) | Sustained release compositions and the process for their preparation | |
| KR910011244A (ko) | 로젠지제 | |
| EP0279149A3 (en) | Benzimidazole derivatives, process for their production and a pharmaceutical composition containing the same | |
| ES2049617B1 (es) | Procedimiento de preparacion de una composicion farmaceutica. | |
| BR9508034A (pt) | Processo e aparelhagem para a preparação de uma unidade comestível que se dissolve rapidamente a referida unidade composição para liberar um ingrediente ativo processo para administração de um ingrediente ativo a um hospedeiro humano e produto provisório para fabricação da unidade comestível | |
| ES2040733T3 (es) | Medicamentos que contienen clodronato y procedimiento para su preparacion. | |
| DE69837997D1 (de) | Lyophilisierbare pharmazeutische plazebozusammensetzung , insbesondere auf basis von proteinen oder polypeptiden, zur nachahmung eines arzneimittels | |
| BR9813752A (pt) | Processo para a produção de formulações farmacêuticas contendo extrato | |
| ATE173608T1 (de) | Präparat gegen haarausfall und brüchiche nägel | |
| ATE85213T1 (de) | Einen wirkstoff und ein in wasser quellendes polymer enthaltendes arzneimittel. | |
| ES334301A1 (es) | Procedimiento para la preparacion de 1,3-dihidro-2-oxo-5- fenil-2h-1,4-benzodiacepinas. | |
| ATE86965T1 (de) | Pharmazeutische kompositionen zum behandeln von adrenoleukodystrophie. | |
| DE69103724D1 (de) | Pharmazeutische zusammensetzungen mit verzögerter freisetzung zur oralen verabreichung sowie deren herstellungsverfahren. | |
| KR880012206A (ko) | 구강질환 치료 조성물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EC2A | Search report published |
Date of ref document: 19911113 Kind code of ref document: A1 Effective date: 19911113 |